Ventilator-associated pneumonia complicating the acute respiratory distress syndrome

Seminars in Respiratory and Critical Care Medicine

Volumn 22, Issue 3, 2001, Pages 317-325

  Iregui, M G ^a   Kollef, M H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ARDS; Bronchoscopy; Complications; Nosocomial infection; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT; OXACILLIN;

ACINETOBACTER; ACUTE RESPIRATORY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; CATHETERIZATION; CAUSE OF DEATH; HAEMOPHILUS INFLUENZAE; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INFECTIOUS COMPLICATION; INFLUENZA; LUNG COMPLICATION; LUNG INFECTION; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; VENTILATOR;

EID: 0034899347     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-15788     Document Type: Review

References (71)

1. Incidence of community-acquired pneumonia requiring hospitalization: Results of a population-based active surveillance study in Ohio
2. Guidelines for prevention of nonsocomial pneumonia
3. Nosocomial infections in medical intensive care units in the United States
4. Mortality and increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients
5. Diagnosis and differential diagnosis of ventilator -associated pneumonia
6. Antimicrobial therapy of ventilator-associated pneumonia: How to select an appropriate drug regimen
7. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria
8. A comparative analysis of patients with early-onset versus late-onset nosocomial pneumonia (NP) in the ICU setting
9. Nosocomial pneumonia
10. Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay
11. Ventilator-associated pneumonia by Staphylococcus aureus: Comparison of methicillin-resistant and methicillin-sensitive episodes
12. Nosocomial respiratory infection
13. Antibiotic resistance in the intensive care unit
14. Hospital-acquired gram-negative rod pneumonias: An overview
15. Pneumonia caused by gram-negative bacilli: An overview
16. Nosocomial infection surveillance
17. Nosocomial pneumonia. A multivariate analysis of risk and prognosis
18. The prevalence of nosocomial infection in intensive care units in Europe: Results of the European Prevalence of Infection in Intensive Care (EPIC) Study
19. Incidence and risk factors of pneumonia acquired in intensive care units: Results from a multicenter prospective study on 996 patients
20. Long-term respiratory support and the risk of pneumonia in critically ill patients
21. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate prophylaxis for stress ulcer: A randomized controlled trial
22. Preventing nosocomial pneumonia; state of the art and perspectives for the 1990s
23. Hospital-acquired pneumonia: Attributable mortality and morbidity
24. Pneumonia in the critically ill hospitalized patient
25. Predominant pathogens in hospital infections
26. The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: A prospective study
27. Incidence of anaerobes in ventilator-associated pneumonia with use of a protected specimen brush
28. Treatment of severe pneumonia in hospitalized patients: Results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastin
29. Nosocomial pneumonia in the critically ill: Product of aspiration or translocation?
30. Pharyngeal aspiration in normal adults and patients with depressed consciousness
31. Pneumonia in intubated trauma patients: Microbiology and outcomes
32. Risk factors for early onset pneumonia in trauma patients
33. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia
34. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation
35. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients
36. Ventilator-associated pneumonia: A multivariate analysis
37. Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia
38. Incidence and risk factors of ventilator-associated pneumonia: A one-year prospective survey
39. Pneumonia in intubated patients: Role of respiratory airway care
40. Risk factors for infection by Acinetobacter baumanii in intubated patients with nosocomial pneumonia
41. Patient transport out of the intensive care unit setting increases the risk of developing ventilator-associated pneumonia
42. Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: Evaluation of outcome
43. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: A pilot study
44. Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia
45. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: A randomized trial
46. Short course empiric antibiotic therapy for pulmonary infiltrates in the intensive care unit: A proposed solution for indiscriminate antibiotic prescription
47. Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia
48. The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination
49. The American-European Consensus Conference on ARDS. Part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute Respiratory Distress Syndrome
50. The acute respiratory distress syndrome
51. A multicenter registry of patients with acute respiratory distress syndrome
52. The adult respiratory distress syndrome
53. Lower respiratory tract colonization and infection during sever acute respiratory distress syndrome: Incidence and diagnosis
54. Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome-incidence, prognosis, and risk factors
55. Pneumonia in acute respiratory distress syndrome: A prospective evaluation of bilateral bronchoscopic sampling
56. Nosocomial pneumonia in patients with acute respiratory distress syndrome
57. Acute respiratory distress syndrome and nosocomial pneumonia
58. The effect of late-onset ventilator-associated pneumonia in determining patient mortality
59. Incidence, site, and outcome of infections in patients with the adult respiratory distress syndrome
60. The influence of mini-BAL cultures on patient outcomes: Implications for the antibiotic management of ventilator-associated pneumonia
61. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia
62. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit
63. The value of routine microbial investigation in ventilator-associated pneumonia
64. Rotation and restricted use of antibiotics ina medical intensive care unit: Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria
65. Histopathologic and microbiologic aspects of ventilator-associated
66. Utility of transbronchial biopsy in patients with acute respiratory failure: A postmortem study
67. Pulmonary infection during the acute respiratory distress syndrome
68. Effect of mechanical ventilation strategy on dissemination of intratracheally instilled Escherichia coli in dogs
69. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome
70. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome
71. Epidemiology and risk factors for nosocomial pneumonia